ROK1 Antibody

What is ROK1 and what are its primary cellular functions?

ROK1, also known as DDX52, HUSSY-19, or DEAD box protein 52, is a DEAD-box RNA helicase that plays crucial roles in cellular function. It is required for efficient ribosome biogenesis and may control cell cycle progression by regulating translation of mRNAs containing terminal oligo pyrimidine (TOP) motifs in their 5' UTRs, such as GTPBP4 .

The protein is essential for cell viability across evolutionary lines, with depletion studies showing inhibition of pre-rRNA processing . Research in Drosophila melanogaster has demonstrated that ROK1 coordinates ribosomal RNA processing, with mutants displaying enlarged nucleoli and developmental defects including stalled ribosome assembly . ROK1's ATP hydrolysis activity has been shown to orchestrate both 40S and 60S ribosome assembly by regulating the release of Rrp5 from pre-40S subunits .

What are the key applications of ROK1 antibodies in research?

ROK1 antibodies serve multiple critical functions in research settings, with applications varying based on antibody specificity and experimental goals:

ROK1 antibodies have been particularly useful in nucleolar research, where they can help visualize the protein's localization and study its interactions with pre-rRNA processing machinery . When combined with fluorescence in situ hybridization (FISH) techniques, these antibodies allow researchers to examine the relationship between ROK1 localization and pre-rRNA processing intermediates containing ETS and ITS1 regions .

How can I distinguish between ROK1 (DDX52) and ROCK1 antibodies?

This is a critical distinction as these proteins are often confused due to their similar names but have entirely different functions and structures:

• Target Molecular Weight: ROK1/DDX52 antibodies should detect a protein of approximately 55-67 kDa , while ROCK1 antibodies detect a much larger protein of approximately 158 kDa .

• Alternative Names: ROK1 antibody product information should list alternative names including DDX52, HUSSY-19, DEAD box protein 52, or ATP-dependent RNA helicase ROK1-like . In contrast, ROCK1 references include terms like "Rho-associated, coiled-coil-containing protein kinase 1" .

• Functional Description: Product information for ROK1 antibodies will mention ribosome biogenesis and RNA processing functions , while ROCK1 antibodies will reference roles in regulating the actomyosin cytoskeleton, cell morphology, or plasma membrane blebbing .

• Sequence Information: The immunogen used to generate the antibody provides definitive identification. ROK1 antibodies are typically raised against recombinant fragments or synthetic peptides from human DDX52 .

When ordering and using these antibodies, carefully review all documentation to ensure you are targeting the intended protein in your research.

How does ROK1 coordinate with Rrp5 during ribosome biogenesis?

ROK1 and Rrp5 exhibit a sophisticated functional relationship during ribosome biogenesis that is central to proper ribosomal assembly. Studies have revealed that ROK1's ATP hydrolysis activity is essential for regulating the association of Rrp5 with pre-ribosomal particles .

When ROK1's ATPase activity is impaired (through mutations in the DEAD-box motif), researchers observe:

• Increased retention of Rrp5 on pre-40S ribosomal subunits, with more than 50% decrease in binding of Rrp5 to pre-60S subunits .

• Abnormal accumulation of 23S rRNA (a pre-40S marker) associated with Rrp5-TAP complexes .

• Disrupted A2 cleavage, leading to depletion of 20S rRNA .

In Drosophila studies, Rrp5 signal was found to be highly enriched in the core of the nucleolus in rok1 mutants, suggesting that ROK1 is required for the accurate cellular localization of Rrp5 within the nucleolus . The rrp5 4-2/4-2 mutation displayed significantly increased ITS1 signaling as detected by fluorescence in situ hybridization, along with a reduction in ITS2 .

These findings collectively indicate that ROK1's ATP hydrolysis plays a critical role in orchestrating the dynamic association of Rrp5 with pre-ribosomal particles, effectively functioning as a molecular switch that regulates the release of Rrp5 from pre-40S subunits to allow its binding to pre-60S subunits during ribosome assembly.

What is the impact of ROK1 depletion on nucleolar morphology and pre-rRNA processing?

ROK1 depletion studies have revealed profound effects on nucleolar structure and function, particularly in multicellular eukaryotes where developmental processes rely on precise ribosomal biogenesis. Studies in Drosophila melanogaster have yielded the following observations:

• Nucleolar Enlargement: ROK1-deficient cells display significantly enlarged nucleoli, as visualized through multiple nucleolar markers .

• Excessive Pre-rRNA Accumulation: Stronger Top1-GFP fluorescence is observed in rok1 167/167 mutants, with larger fluorescent area and higher intensity, indicating accumulation of pre-rRNAs in the nucleolus .

• Transcriptional Dysregulation: The levels of external transcribed spacer (ETS)-containing intermediate precursors significantly increase in ROK1 mutants, suggesting excessive transcription of pre-rRNA .

• Processing Defects: When normalized to ETS levels, ITS1-containing intermediate precursors show approximately 100% increase in rok1 167/167 and 50% increase in rok1 141/141 mutants .

• Developmental Consequences: ROK1 null mutant Drosophila larvae die during the second-instar stage, demonstrating the essential nature of this protein in development .

FISH experiments in salivary glands revealed that ETS- and ITS1-containing pre-rRNAs produced in the nucleolus show significantly increased fluorescence in ROK1-deficient cells, providing visual confirmation of stalled ribosome assembly and pre-rRNA processing .

These findings substantiate a model where ROK1 serves as a critical coordinator of pre-rRNA processing events, with its absence leading to processing bottlenecks that manifest as enlarged nucleoli filled with partially processed pre-rRNAs.

How do experimental factors affect ROK1 antibody specificity and how can non-specific binding be mitigated?

Achieving high specificity with ROK1 antibodies requires understanding the experimental factors that influence antibody performance. Research has identified several critical considerations:

When troubleshooting specificity issues with ROK1 antibodies, researchers should:

• Validate specificity through knockout/knockdown controls to ensure that the detected band diminishes accordingly.

• Consider the use of recombinant fragment-derived antibodies versus synthetic peptide-derived antibodies - the former (like ab183848) target human DDX52 aa 1-350 , while the latter (like ab225708) target the C-terminal region , potentially resulting in different specificity profiles.

• Be aware that multiple isoforms of ROK1/DDX52 may exist, with predicted band sizes of both 55 kDa and 67 kDa reported in literature . This knowledge is crucial when interpreting Western blot results that may show multiple bands.

• For immunofluorescence applications, include appropriate negative controls and counterstain with nucleolar markers (such as fibrillarin) to confirm the expected nucleolar localization pattern of ROK1.

What are the optimal protocols for using ROK1 antibodies in different experimental applications?

Optimized protocols for ROK1 antibody applications vary by technique and research objective. Based on published literature and product documentation, the following methodologies are recommended:

Western Blot Protocol for ROK1 Detection:

• Sample Preparation: Prepare whole cell lysates using RIPA buffer supplemented with protease inhibitors. For optimal results with HeLa cells, use 50 μg of lysate per lane .

• Gel Electrophoresis: Separate proteins using 10% SDS-PAGE.

• Transfer: Transfer proteins to PVDF membrane at 100V for 1 hour.

• Blocking: Block membrane with 5% BSA in TBST for 1 hour at room temperature.

• Primary Antibody: Dilute ROK1 antibody to working concentration (ranges from 0.04 μg/mL to 1/1000 dilution ) in blocking solution. Incubate overnight at 4°C.

• Washing: Wash membrane 3-5 times with TBST, 5 minutes each.

• Secondary Antibody: Incubate with HRP-conjugated anti-rabbit IgG at appropriate dilution for 1 hour at room temperature.

• Development: Visualize using enhanced chemiluminescence. Expect bands at approximately 55-67 kDa .

Immunofluorescence Protocol:

• Cell Preparation: Culture cells on coverslips to 70-80% confluence. HepG2 cells have been validated for ROK1 immunofluorescence studies .

• Fixation: Fix with 4% paraformaldehyde for 15 minutes at room temperature.

• Permeabilization: Permeabilize with 0.1% Triton X-100 in PBS for 10 minutes.

• Blocking: Block with 1% BSA in PBS for 30 minutes.

• Primary Antibody: Apply ROK1 antibody at 1/500 dilution in blocking buffer. Incubate overnight at 4°C.

• Washing: Wash 3 times with PBS, 5 minutes each.

• Secondary Antibody: Apply fluorophore-conjugated secondary antibody for 1 hour at room temperature.

• Nuclear Counterstain: Counterstain with Hoechst 33342 or DAPI.

• Mounting: Mount slides with anti-fade mounting medium.

For nucleolar co-localization studies, including fibrillarin or nucleolin antibodies can provide validation of ROK1's nucleolar localization.

How can I design experiments to investigate ROK1's role in pre-rRNA processing pathways?

Investigating ROK1's function in pre-rRNA processing requires a multifaceted experimental approach. Based on published research methodologies, the following experimental design strategy is recommended:

• Genetic Manipulation of ROK1 Expression:

  • Generate conditional knockdown or knockout models using CRISPR/Cas9 or RNAi technologies

  • Create ATPase-deficient mutants by targeting the conserved DEAD-box motif

  • Design complementation experiments with wild-type ROK1 to confirm phenotype specificity

• Pre-rRNA Processing Analysis:

  • Northern blot analysis using probes specific for different pre-rRNA species (ETS, ITS1)

  • Quantitative RT-PCR to measure relative levels of different pre-rRNA intermediates

  • Pulse-chase labeling with 3H-uridine or 4-thiouridine to track rRNA maturation kinetics

• Fluorescence In Situ Hybridization (FISH):

  • Design and validate probes targeting ETS and ITS1 regions of pre-rRNA

  • Perform FISH in wild-type and ROK1-depleted cells to visualize pre-rRNA accumulation

  • Combine with immunofluorescence (IF) for ROK1 and nucleolar markers for co-localization studies

• Protein-RNA Interaction Studies:

  • RNA immunoprecipitation (RIP) using ROK1 antibodies to identify associated RNA species

  • Crosslinking and immunoprecipitation (CLIP) to map ROK1 binding sites on pre-rRNAs

  • In vitro RNA binding and ATPase assays with recombinant ROK1 protein

• Protein Interaction Analysis:

  • Co-immunoprecipitation experiments to identify ROK1 protein partners, particularly Rrp5

  • Proximity ligation assays to visualize ROK1-Rrp5 interactions in situ

  • Tandem affinity purification followed by mass spectrometry to characterize ROK1-containing complexes

• Nucleolar Morphology Assessment:

  • Immunofluorescence with nucleolar markers (fibrillarin, nucleolin)

  • Transmission electron microscopy to analyze nucleolar ultrastructure

  • Live cell imaging with fluorescently tagged ROK1 to monitor dynamics during ribosome biogenesis

The experimental results should be validated across multiple cell types or model organisms to establish evolutionary conservation of ROK1 function, as studies have shown important roles in both yeast and Drosophila systems .

What controls and validation steps are essential when using ROK1 antibodies in research?

Rigorous validation of ROK1 antibodies is essential for generating reliable scientific data. The following control and validation strategies should be implemented:

Essential Positive Controls:

• Recombinant ROK1/DDX52 protein: Use as a positive control in Western blot analyses to confirm antibody specificity and determine limit of detection.

• Cell lines with known ROK1 expression: HeLa cells and Raji whole cell lysates have been validated for ROK1 detection with specific antibodies .

• Tissues with established ROK1 expression patterns: Include human or mouse tissues with documented ROK1 expression profiles as reference standards.

Critical Negative Controls:

• ROK1 knockout/knockdown samples: Generate CRISPR/Cas9 knockout or siRNA knockdown samples to confirm antibody specificity. Signal should be significantly reduced or abolished in these samples.

• Isotype control antibodies: Use matched isotype control antibodies at the same concentration to assess non-specific binding.

• Secondary antibody-only controls: Omit primary antibody to identify potential secondary antibody non-specific binding.

Cross-Reactivity Assessment:

• Peptide competition assay: Pre-incubate the antibody with excess immunizing peptide to block specific binding sites. This should eliminate specific signals while leaving non-specific binding unaffected.

• Cross-species reactivity testing: If using the antibody in non-human samples, validate species cross-reactivity with appropriate positive and negative controls from target species.

Application-Specific Validation:

Documentation Requirements:

• Include complete antibody information in publications: catalog number, lot number, dilution, incubation conditions, and validation methods.

• Document all modifications to manufacturer's recommended protocols.

• Present both positive and negative control data alongside experimental results.

By implementing these validation strategies, researchers can ensure that findings attributed to ROK1 localization or function are based on specific antibody-target interactions rather than experimental artifacts.